The regulation of NK cell function and development

被引:8
作者
Chung, Jin Woong [1 ]
Yoon, Suk Ran [1 ]
Choi, Inpyo [1 ]
机构
[1] Korea Res Inst Biosci & Biotechnol, Stem Cell Res Ctr, Taejon 305333, South Korea
关键词
hematopoietic stem cells; Natural killer; development; NK cell activity; NK cell therapy; review;
D O I
10.2741/3164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NK cells are the lymphocytes that are differentiated from hematopoietic stem cells in bone marrow (BM) through sequential acquisition of functional receptors. They are one of the critical components of innate immune system. The process of NK differentiation involves a variety of factors such as cytokines, membrane factors, and transcription factors in addition to BM microenvironment. NK cells express their own activating and inhibitory receptors. The cytolytic functions of NK cells against target cells are determined by the balance between theses activating and inhibitory receptors. NK cells discriminate self from non-self by MHC class I binding inhibitory receptor. Once NK cell inhibitory receptors bound to their MHC class I-ligand, the target cells are protected from NK cell-mediated cytotoxicity. The cytolytic effector functions as well as the characteristic surface phenotypes of NK cells are acquired during the differentiation process. NK cells are emerging to apply as therapeutic agents against a variety of cancers by manipulating differentiation processes and intrinsic activities of the NK cell.
引用
收藏
页码:6432 / 6442
页数:11
相关论文
共 104 条
[1]   Monoclonal antibody therapy of cancer [J].
Adams, GP ;
Weiner, LM .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1147-1157
[2]   Interleukin-2, interleukin-15, and their roles in human natural killer cells [J].
Becknell, B ;
Caligiuri, MA .
ADVANCES IN IMMUNOLOGY, VOL 86, 2005, 86 :209-239
[3]   Lack of natural killer cell precursors in fetal liver of Ikaros knockout mutant mice [J].
Boggs, SS ;
Trevisan, M ;
Patrene, K ;
Geogopoulos, K .
NATURAL IMMUNITY, 1998, 16 (04) :137-145
[4]  
Brandau S, 2001, INT J CANCER, V92, P697, DOI 10.1002/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO
[5]  
2-Z
[6]   IL-15/IL-15 receptor biology: A guided tour through an expanding universe [J].
Budagian, Vadirn ;
Bulanova, Elena ;
Paus, Ralf ;
Bulfone-Paus, Silvia .
CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (04) :259-280
[7]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[8]   Immunoglobulin superfamily inhibitory receptors: From natural killer cells to antigen-presenting cells [J].
Colonna, M .
RESEARCH IN IMMUNOLOGY, 1997, 148 (03) :169-171
[9]   Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells [J].
Colucci, F ;
Samson, SI ;
DeKoter, RP ;
Lantz, O ;
Singh, H ;
Di Santo, JP .
BLOOD, 2001, 97 (09) :2625-2632
[10]   ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor [J].
Cosman, D ;
Müllberg, J ;
Sutherland, CL ;
Chin, W ;
Armitage, R ;
Fanslow, W ;
Kubin, M ;
Chalupny, NJ .
IMMUNITY, 2001, 14 (02) :123-133